ARCHIVES

Funding Opportunities: NCI Offers Grant Supplements

This article is from The Cancer Letter archive.

Vol. 25 No. 09 | March 5, 1999

Download PDF Visit The Full Archive

Related Articles

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

October 25, 1985

Also M.D. Anderson awarded three new, one renewal SPORE grant.

October 31, 2003

Concept Approval Given To $7 Million In OD Recompetitions, Renewals

May 28, 1982

Risk Assessment Program Turns 30: Fox Chase Program Helps People Understand Genetic Risks for Cancer

October 25, 2021

Sen. Specter Vows to “Stay and Fight” For Health, Education, On Subcommittee.

February 11, 2005